×
0 0 0 0 0 0 0 0
Stockreport

Don't Give Up On Verastem [Seeking Alpha]

VERASTEM (VSTM)  More Company Research Source: Seeking Alpha
Last verastem earnings: 11/7 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF Summary Almost anyone following Verastem ( VSTM ) knows they recently had their drug, COPIKTRA, approved by the FDA for treatment of CLL/SLL/FLL in a 3 rd line setting. Due to COPIKTRA filling a unique niche of being an oral, monotherapy treatment in the CLL/SLL/FLL space, I believe they will get a healthy portion of market share in this 3 rd line setting. I have owned shares of VSTM since early 2017 and while I thought a pullback was possible, I now want to reiterate what a Strong Buy VSTM is going forward. First Let's take a look at what has led to the steep price decline. 3 Reasons for the Price Decline 1) Irrationally Exuberant Valuations During the weeks leading up to the FDA decision date, there were a number of articles and comments in those articles that were getting out of hand with the valuations, in my opinion. I don't mean to criticize just for the sake of it, but rather to temper expectations and help investors realize a pullback after what a great 2018 [Read more]

IMPACT SNAPSHOT EVENT TIME: VSTM
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
VSTM alerts
from News Quantified
Opt-in for
VSTM alerts

from News Quantified
Opt-in for
VSTM alerts

from News Quantified